Alex3 suppresses non–small cell lung cancer invasion via AKT/Slug/E-cadherin pathway

Alex3, is a newly identified mitochondrial protein, regulates mitochondrial dynamics and is involved in neural development. However, its expression pattern and clinicopathological relevance in human tumors are still unclear. In this study, Immunohistochemistry assay was performed in 109 cases of lun...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiang Du, Xiupeng Zhang, Haijing Zhou, Yuan Miao, Yong Han, Qiang Han, Enhua Wang
Format: Article
Language:English
Published: SAGE Publishing 2017-07-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317701441
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850045276251750400
author Jiang Du
Xiupeng Zhang
Haijing Zhou
Yuan Miao
Yong Han
Qiang Han
Enhua Wang
author_facet Jiang Du
Xiupeng Zhang
Haijing Zhou
Yuan Miao
Yong Han
Qiang Han
Enhua Wang
author_sort Jiang Du
collection DOAJ
description Alex3, is a newly identified mitochondrial protein, regulates mitochondrial dynamics and is involved in neural development. However, its expression pattern and clinicopathological relevance in human tumors are still unclear. In this study, Immunohistochemistry assay was performed in 109 cases of lung cancer samples and found that Alex 3 expression in lung cancer tissues was significantly lower than adjacent normal lung tissues (28.4% vs 52.6%, p < 0.001). Sequent statistical analysis indicated that negative Alex3 expression was significantly associated with advanced tumor–node–metastasis stages (p = 0.001), positive lymph node metastasis (p = 0.005), and poor prognosis (p = 0.008). After overexpression of Alex3, levels of p-AKT and Slug were downregulated, while level of E-cadherin was upregulated, which results in the inhibition of invasion and migration ability of lung cancer cells. In conclusion, reduction of Alex3 correlates with the development of non–small cell lung cancer and predicts adverse clinical outcome of non–small cell lung cancer patients. The effect of Alex3 on inhibiting invasion and migration may attribute to upregulation of E-cadherin expression through AKT–Slug pathway inactivation.
format Article
id doaj-art-a114e8e79fbb492eb21eb8e4e427a379
institution DOAJ
issn 1423-0380
language English
publishDate 2017-07-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-a114e8e79fbb492eb21eb8e4e427a3792025-08-20T02:54:43ZengSAGE PublishingTumor Biology1423-03802017-07-013910.1177/1010428317701441Alex3 suppresses non–small cell lung cancer invasion via AKT/Slug/E-cadherin pathwayJiang DuXiupeng ZhangHaijing ZhouYuan MiaoYong HanQiang HanEnhua WangAlex3, is a newly identified mitochondrial protein, regulates mitochondrial dynamics and is involved in neural development. However, its expression pattern and clinicopathological relevance in human tumors are still unclear. In this study, Immunohistochemistry assay was performed in 109 cases of lung cancer samples and found that Alex 3 expression in lung cancer tissues was significantly lower than adjacent normal lung tissues (28.4% vs 52.6%, p < 0.001). Sequent statistical analysis indicated that negative Alex3 expression was significantly associated with advanced tumor–node–metastasis stages (p = 0.001), positive lymph node metastasis (p = 0.005), and poor prognosis (p = 0.008). After overexpression of Alex3, levels of p-AKT and Slug were downregulated, while level of E-cadherin was upregulated, which results in the inhibition of invasion and migration ability of lung cancer cells. In conclusion, reduction of Alex3 correlates with the development of non–small cell lung cancer and predicts adverse clinical outcome of non–small cell lung cancer patients. The effect of Alex3 on inhibiting invasion and migration may attribute to upregulation of E-cadherin expression through AKT–Slug pathway inactivation.https://doi.org/10.1177/1010428317701441
spellingShingle Jiang Du
Xiupeng Zhang
Haijing Zhou
Yuan Miao
Yong Han
Qiang Han
Enhua Wang
Alex3 suppresses non–small cell lung cancer invasion via AKT/Slug/E-cadherin pathway
Tumor Biology
title Alex3 suppresses non–small cell lung cancer invasion via AKT/Slug/E-cadherin pathway
title_full Alex3 suppresses non–small cell lung cancer invasion via AKT/Slug/E-cadherin pathway
title_fullStr Alex3 suppresses non–small cell lung cancer invasion via AKT/Slug/E-cadherin pathway
title_full_unstemmed Alex3 suppresses non–small cell lung cancer invasion via AKT/Slug/E-cadherin pathway
title_short Alex3 suppresses non–small cell lung cancer invasion via AKT/Slug/E-cadherin pathway
title_sort alex3 suppresses non small cell lung cancer invasion via akt slug e cadherin pathway
url https://doi.org/10.1177/1010428317701441
work_keys_str_mv AT jiangdu alex3suppressesnonsmallcelllungcancerinvasionviaaktslugecadherinpathway
AT xiupengzhang alex3suppressesnonsmallcelllungcancerinvasionviaaktslugecadherinpathway
AT haijingzhou alex3suppressesnonsmallcelllungcancerinvasionviaaktslugecadherinpathway
AT yuanmiao alex3suppressesnonsmallcelllungcancerinvasionviaaktslugecadherinpathway
AT yonghan alex3suppressesnonsmallcelllungcancerinvasionviaaktslugecadherinpathway
AT qianghan alex3suppressesnonsmallcelllungcancerinvasionviaaktslugecadherinpathway
AT enhuawang alex3suppressesnonsmallcelllungcancerinvasionviaaktslugecadherinpathway